Protective Activity and Safety of Acellular Pertussis Vaccine from Vaccine and Freshly Isolated Strain Bordetella pertussis
Goal. Study of the protective activity and safety of acellular pertussis vaccine (APV) using freshly isolated strain of B. pertussis. Materials and methods. Mice-hybrids F1 (CBAxC57Bl6). The B. pertussis strains: vaccine strains No. 305, No. 203, freshly isolated strain No. 287, the test neurotropic...
Saved in:
| Main Authors: | E. M. Zaitsev, I. G. Bazhanova, M. V. Britsina |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Numikom LLC
2017-04-01
|
| Series: | Эпидемиология и вакцинопрофилактика |
| Subjects: | |
| Online Access: | https://www.epidemvac.ru/jour/article/view/251 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Safety of Combination Vaccines with Whole Cell Pertussis Component
by: O. V. Perelygina, et al.
Published: (2016-12-01) -
Acellular Pertussis Vaccine from Antigens of Freshly Isolated and Vaccine Strains of Bordetella pertussis with Different Genotypic Characteristics
by: E. M. Zaitsev, et al.
Published: (2021-09-01) -
Pertactin deficiency of Bordetella pertussis: Insights into epidemiology, and perspectives on surveillance and public health impact
by: Ulrich Heininger, et al.
Published: (2024-12-01) -
Prevalence of Pertactin-Deficient Bordetella pertussis Isolates, Slovenia
by: Alex-Mikael Barkoff, et al.
Published: (2024-11-01) -
As pertussis returns to pre-COVID19 endemicity, vaccination remains our best ally against an evolving Bordetella pertussis
by: Zeng Mei, et al.
Published: (2025-12-01)